Prostate Cancer Trial, Recruiting NCT07710807 Sponsor: Ankara Etlik City Hospital Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT07710807
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male and between 50 and 75 years old.
  • People who have had a prostate MRI scan that showed a suspicious area rated as PI-RADS 3, 4, or 5 (a scoring system used to describe how concerning a finding looks on the scan).
  • People whose doctor has determined that a prostate biopsy is needed.
  • People who are willing to take part and have agreed to participate by signing a consent form.

Who may not be able to join:

  • People who have already been diagnosed with prostate cancer.
  • People who currently have an active urinary tract infection.
  • People who have a blood clotting condition or bleeding disorder that would make having a prostate biopsy unsafe.
  • People who have not had a multiparametric prostate MRI scan performed.
  • People for whom a prostate biopsy has not been recommended by their doctor.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 554 838 4510

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara Etlik City Hospital
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
31 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Clinically significant prostate cancer detection rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov